NCT06048718 2026-03-10
TUXEDO-4
MedSIR
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT05633979 2026-01-20
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT06663787 2025-11-28
HER2 CR
Nagoya City University
Active not recruiting
NCT05704829 2025-11-19
ADAPTHER2-IV
West German Study Group
Phase 2 Active not recruiting